Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function

NCT01442129 is registered in ClinicalTrials.gov with Deborah Ascheim as lead sponsor.

NCT NCT01442129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function
Lead sponsor
Deborah Ascheim
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
August 31, 2013
Enrollment
30 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, heart failure, ventricular dysfunction